DERM Butterfly Strategy
DERM (Journey Medical Corporation), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.
DERM (Journey Medical Corporation) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $182.2M, a beta of 1.10 versus the broader market, a 52-week range of 4.31-9.555, average daily share volume of 287K, a public-listing history dating back to 2021, approximately 41 full-time employees. These structural characteristics shape how DERM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.10 places DERM roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a butterfly on DERM?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current DERM snapshot
As of June 30, 2026, spot at $7.11, ATM IV 445.30%, IV rank 90.70%, expected move 127.66%. The butterfly on DERM below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this butterfly structure on DERM specifically: DERM IV at 445.30% is rich versus its 1-year range, which makes a premium-buying DERM butterfly relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 127.66% (roughly $9.08 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DERM expiries trade a higher absolute premium for lower per-day decay. Position sizing on DERM should anchor to the underlying notional of $7.11 per share and to the trader's directional view on DERM stock.
DERM butterfly setup
The DERM butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DERM near $7.11, the first option leg uses a $6.75 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DERM chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DERM shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $6.75 | N/A |
| Sell 2 | Call | $7.11 | N/A |
| Buy 1 | Call | $7.47 | N/A |
DERM butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
DERM butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on DERM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on DERM
Butterflies on DERM are pinning bets - traders use them when they expect DERM to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
DERM thesis for this butterfly
The market-implied 1-standard-deviation range for DERM extends from approximately $-1.97 on the downside to $16.19 on the upside. A DERM long call butterfly is a pinning play: it pays maximum at the middle strike if DERM settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current DERM IV rank near 90.70% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on DERM at 445.30%. As a Healthcare name, DERM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DERM-specific events.
DERM butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DERM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DERM alongside the broader basket even when DERM-specific fundamentals are unchanged. Always rebuild the position from current DERM chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on DERM?
- A butterfly on DERM is the butterfly strategy applied to DERM (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With DERM stock trading near $7.11, the strikes shown on this page are snapped to the nearest listed DERM chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are DERM butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the DERM butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 445.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a DERM butterfly?
- The breakeven for the DERM butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DERM market-implied 1-standard-deviation expected move is approximately 127.66%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on DERM?
- Butterflies on DERM are pinning bets - traders use them when they expect DERM to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current DERM implied volatility affect this butterfly?
- DERM ATM IV is at 445.30% with IV rank near 90.70%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.